ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,4,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,8,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
2,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3,1,Headache,Headaches NEC,Headaches,Nerv,N
4,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
6,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
6,4,Papillitis,Inflammations,General system disorders NEC,Genrl,N
6,5,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
6,6,Scleral oedema,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6,7,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6,9,Visual field defect,Visual field disorders,Vision disorders,Eye,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
12,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
12,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,3,Nephritis,Nephritis NEC,Nephropathies,Renal,N
12,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
13,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
13,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
13,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
13,5,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
14,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
14,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
14,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
14,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
14,5,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
15,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
15,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
16,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
18,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
18,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
18,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
19,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
20,1,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
21,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
22,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
22,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
23,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,3,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
23,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
23,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
24,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
24,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
24,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,2,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
25,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,5,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
25,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
26,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
26,3,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
27,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
28,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
28,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
29,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
